Early virologic outcomes and hematologic safety of direct-acting antiviral (DAA)-based therapy in US veterans with cirrhosis from hepatitis C virus (HCV) genotype 1 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Hwang, E. W., Thomas, I., Belperio, P. S., Cheung, R., Mole, L. A., Backus, L. I. WILEY-BLACKWELL. 2012: 1001A–1002A

View details for Web of Science ID 000310955603334